- Dr. Billy W. Loo, Jr., M.D., Ph.D
- Kenneth W. Herwig, PhD
Dr. Billy W. Loo, Jr., M.D., Ph.D
Billy W. Loo, Jr., M.D., Ph.D. is a Professor of Radiation Oncology, a member of the Molecular Imaging Program at Stanford (MIPS) in the Department of Radiology, and a member of the Stanford Cancer Institute, in the School of Medicine. He is a physician-scientist Radiation Oncologist and Bioengineer who directs the Thoracic Radiation Oncology Program at Stanford.
His clinical specialties are state-of-the-art radiation therapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and 4-D image-guided radiation therapy for lung tumors. Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member, chair, or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, including the National Comprehensive Cancer Network (NCCN), American College of Radiology (ACR), and American Society of Radiation Oncology (ASTRO).
His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer, and development of new medical imaging methods for measuring organ function and predicting response to cancer treatment. As part of this work, he leads a clinical and preclinical research program in molecular imaging, particularly using novel PET tracers for tumor hypoxia (EF5), tumor proliferation (FLT), and neuroinflammation (PBR06). He also co-leads clinical trials of novel applications of SABR including treatment of pulmonary emphysema and cardiac arrhythmias.
Since conceiving of a fundamentally new approach to delivering ultra-rapid, ultra-precise radiation therapy, pluridirectional high-energy agile scanning electronic radiotherapy (PHASER), Dr. Loo's major laboratory research focus has been to co-lead a collaborative effort between the Stanford Cancer Institute and SLAC National Accelerator Laboratory to develop PHASER into a transformative yet clinically practical technology. This program comprises both technology development and fundamental research on the radiobiology of extremely rapid FLASH radiation therapy to optimize the biological therapeutic index.
Dr. Loo received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Oncology residency training at Stanford University. He is certified by the American Board of Radiology in Radiation Oncology
Kenneth W. Herwig, PhD
Dr. Ken Herwig is Technical Director of the Spallation Neutron Source (SNS) Second Target Station (STS) Project at the Oak Ridge National Laboratory (ORNL). STS will be a new, high-brightness neutron source using one out of four proton pulses produced by the upgraded SNS accelerator to provide new neutron scattering capabilities to US researchers.
He is an expert in neutron scattering methods and technologies, having served on many national and international advisory committees for new neutron sources and instruments. He has over 35 years of experience using, constructing, developing, and operating neutron sources and neutron scattering instrumentation. His career has had dual objectives of using neutron scattering methods to study complex fluids and interfaces and to develop cutting-edge neutron technologies and instrumentation. Prior to becoming Technical Director, he led the STS Instrument Systems group which is responsible to construct the initial neutron scattering instruments at the STS and ensure that facility design and interfaces support future full build-out of a complete instrument suite. He led the ORNL Laboratory Directed Research & Development effort that developed the initial compact source geometry that is the basis of the high neutron brightness STS design and has been engaged in STS concept development and planning since its beginning.
He joined ORNL in 1998 as the first instrument scientist for the original SNS Project where he led the design and construction of the BaSiS near-backscattering neutron spectrometer which continues to support about 25 to 30 science publications each year. He has served in many leadership and management roles within the ORNL Neutron Sciences Directorate since its creation in 2006. Prior to joining the STS Project, he led the Instrument Methods, Projects and Technologies Group that focused on advancing state of the art in neutron sciences and technologies. From 2015 to 2018, he managed investment in neutron instrument improvements and upgrades at ORNL.
Ken received his BS in physics and computer science and MS in physics from Southern Illinois University Edwardsville and his PhD in physics from the University of Illinois at Urbana-Champaign.